Introduction

23
Milk and dairy products are widely consumed around the world on a daily basis. They are not 24 only an important source of nutrients in the human diet, but also represent important value in 25 the food chain providing opportunities for farmers, food processors, and retailers to contribute 26 to increased food security and poverty alleviation poverty (1) . Therefore any change in milk 27 and dairy consumption will have multiple impacts on human and animal health, environment, 28 food security, and economics. Indeed, according to an OECD-FAO report, milk production is worldwide. In the UK there has been a significant decrease in death rates since 1961, and due 76 to a combination of better healthcare and preventative strategies, in 2012 CVD became the 77 second main cause of death (CVD caused 28% of all death and cancer 29%) (10) .
78
Approximately seven million people live with CVD in the UK which costs £19 billion each 79 year (including premature death, lost productivity, hospital treatment, prescriptions) resulting 80 in a significant economic burden (10) . Premature death from CVD can be prevented by 81 improving modifiable risk factors. For example, it has been estimated that in the general 82 population increasing physical activity, smoking cessation and dietary changes can lead to 83 50%, 20-30% and 15-40% mortality risk reduction, respectively (11) . High BP (hypertension) is the key modifiable risk factor of CVD and of stroke in particular.
Nearly 30% of adults in the UK have high BP, however only half of them are aware of it and 86 even less receive treatment (10) . High BP is present when systolic blood pressure (SBP) is ≥140 87 mmHg and/or diastolic blood pressure (DBP) is ≥90 mmHg (12) . It is important to treat 88 hypertension and maintain BP in the normal range as elevated BP can cause irreversible 89 damage to different organs such as kidneys, heart and eyes (12) .
91
Long-term studies on blood pressure 92 We have recently reviewed the evidence from RCTs on the antihypertensive effects of milk 93 proteins and peptides (13) . For that review we systematically searched and reviewed the 94 literature until December 2012. There was an imbalance in the literature as more RCTs were 95 conducted using mainly one type of casein-derived peptides, called lactotripeptides (LTP).
96
We, therefore conducted an updated meta-analysis on the impact of LTP on BP (14) , which 97 included all available and relevant RCTs and detailed subgroup and regression analyses which 98 were somewhat limited in previous meta-analyses in this area (15) (16) (17) (18) . We found a small, but 99 significant reduction in both SBP (−2.95 mmHg (95% CI: −4.17, −1.73; p < 0.001)) and processes (22) . Intriguingly, we also found a "small-study effect", and when all bias was 117 considered it shifted the treatment effect towards a less significant SBP and non-significant 118 DBP reduction in response to LTP supplementation. We concluded that with potential bias 119 considered, LTP consumption may still be effective in lowering blood pressure in mildly 120 hypertensive or hypertensive groups (14) .
121
During our systematic literature search (13) we found that there were very few studies 122 investigating the BP-lowering effects of other casein-derived peptides in humans (23) (24) (25) (26) (27) .
123
Furthermore these studies were limited, used different types of peptides and were often 124 uncontrolled with poor methodological and study design. Due to these inconsistencies in 125 study design, it was impossible to compare these data and no firm conclusion could be drawn 126 on the antihypertensive effects of casein-derived peptides. Similarly, we found a limited 127 number of RCTs conducted using intact whey or whey-derived peptides assessing their
128
antihypertensive effects in humans (28) (29) (30) (31) (32) (33) . These trials seems to be of higher quality than 129 studies on casein-derived peptides, however the findings of these studies were also 130 inconsistent (13) . . However it is of note that this
196
technique requires extensive training and is operator dependent, which may limit its value.
197
Arterial stiffness is a measure of arterial elasticity which is the ability to expand and contract . Pulse wave velocity (PWV) is considered to be the 'gold-standard' to measure 202 arterial stiffness and has a substantial predictive value for CVD events (45) .
204
Long-term studies on vascular function 205 Our previous review also evaluated the health effects of milk proteins and/or their peptides on 206 vascular function (13) . In brief, we identified nine chronic RCTs (33, (46) (47) (48) (49) (50) (51) (52) (53) , of which eight used 207 lactotripeptides (46) (47) (48) (49) (50) (51) (52) (53) (54) and one trial used intact casein and whey (33) . . (58) . Therefore it is important to determine the effect on other 242 mediators of risk that may indirectly affect BP.
243
Glycaemic control
245
Insulin has a range of biological actions within the human body (64) , not only has it a key 246 regulatory role in metabolic energy disposal and storage in tissues, but it is responsible for 247 cell growth and development (65) , ion transport (66) , and sympathetic nervous system activity (67) .
248
In addition, insulin has haemodynamic activities such as increasing blood flow and cardiac 249 output, probably via increased NO production (64) . Giugliano et al. demonstrated insulin 250 release after an intravenous infusion of L-arginine resulted in improvements in FMD (68) .
251
However Gates et al. showed an insulin-independent vasodilation after L-arginine 252 administration (69) . Similarly, Ballard and colleagues reported an insulin-independent FMD 253 improvement in response to the acute ingestion of a whey-derived peptide, NOP-47 (55) .
254
It is well established that food proteins and more specifically AAs acutely stimulate insulin 255 secretion (70) with several AAs possessing direct insulinotropic effects (71, 72) . Both whey and 256 casein appear to increase insulin secretion, however to different extents (73) . This may be due 257 to their effect on gastric emptying, absorption and kinetics, since the insulin responses seemed 258 to correlate with the increase in plasma AA concentration after protein ingestion (74) . Likewise,
259
hydrolysates appear to increase insulin production more than intact proteins (75) .
260
It is not yet known how milk proteins exert their beneficial effects on glucose homeostasis, . This may be via the regulation 264 of both ATP production (by metabolic oxidation and allosteric activation of glutamate 265 dehydrogenase) and K ATP activity (77) . Similarly, BCAA and particularly leucine, has been 266 reported to activate the mammalian rapamycin (mTOR) pathway resulting in a higher incretin 267 hormone (insulin, glucagon-like peptide 1 (GLP-1) and gastric inhibitory peptide (GIP)) 268 synthesis (77, 78) . GIP is also known as glucose-dependent insulinotropic peptide, synthesised 269 by K cells found in the mucosa of the duodenum and jejunum in response to food ingestion,
270
which may subsequently further induce insulin production (79) . While the effect of GIP appears 271 to be more pronounced at normoglycaemic levels, GLP-1 is more active during hyperglycaemia (79) . Jakubowitz and Froy showed that whey protein drink increased GIP 273 response (+80%) in healthy adults, yet a mixture of BBCA mimicking the supply of AA in 274 whey protein, failed to exert the same effect (80) . Therefore they suggested that certain 275 bioactive peptides and/or AAs deriving from whey protein during digestion may be 276 responsible for this action (80) . GLP-1 is a potent antihyperglycemic hormone secreted by 277 intestinal L cells (79) . Interestingly, it has been shown to possess cardioprotective effects, which 278 may be further complemented by natriuretic and antioxidative stress on the kidneys leading to 279 beneficial impacts on BP and vasculature (81) . This warrants further consideration in future 280 research when the effects of milk proteins are assessed on the cardiovascular system.
281
Additionally, GLP-1 was more pronounced in healthy subjects after whey consumption 282 compared to casein or soya, however after 2 hours of ingestion the concertation of the 283 hormone decreased, while it continued to increase after casein (80, 82, 83) . This may be explained processes, it has a distinct effect on glucose homeostasis by degrading incretin hormones:
289
GLP-1 and GIP (84) . Whereas there is a definite lack of human studies examining the effects of 290 DPP-IV inhibitory peptides deriving from milk proteins; some in silico (computer-aided), in 291 vitro and limited animal studies suggesting a potential role in controlling glucose metabolism.
292
Lacroix and Li-Chan proposed that casein appears to be a better source of DPP-IV inhibitory 293 peptides than whey protein (85) . However, in vitro and in vivo studies suggest that whey protein 294 may be equal or a better source of these inhibitory peptides (for review see :(86) hydrolysate on C-reactive protein (CRP), a systemic inflammatory marker (133) . Nine RCTs
404
were included which showed a small, non-significant reduction in CRP 0.42mg/L (95% CI
405
−0.96, 0.13). Sub-group analyses suggested that >20 g/day may be more effective, and elevated 406 baseline CRP level (≥3 mg/L) could be more responsive to whey or whey peptides 407 consumption (133) . Similarly, Arnberg et al. reported no change in CRP in adolescence after whey, 408 casein or skim milk consumption for 12 weeks (35) . 409 patients with chronic obstructive pulmonary disease after whey intervention compared with 414 control group (134) . Likewise, IL-6 and TNF-α were decreased after lactoferrin consumption for six 415 months in postmenopausal women (135) . Similarly Hirota et al. reported decreased levels of TNF-α 416 in mildly hypertensive subjects fed with the casein-derived lactotripeptides (46) ( Table 5. ).
418
Long-term studies on inflammation and oxidative stress 419 Pal and Ellis, also reported no change in IL-6, IL-8 and TNF-α in a postprandial study 420 investigating whey and casein (32) . Likewise, a whey-derived peptide, NOP-47, also failed to molecule-1) and chemokines (56) . However consumption of a cake containing whey protein 424 after exhaustive cycling in nine subjects reported reduced levels of CRP and IL-6 by 46% and They reported that all meals increased CCL//RANTES, however the smallest increase was observed after the whey protein meal. MCP-1 was initially suppressed after all meals, and the 430 meal containing whey protein induced the smallest overall postprandial suppression (137) 431 (Table 5. ).
432
The mechanism of action of milk proteins on oxidative stress and inflammation are unclear
433
but Ca may supresses the pro-inflammatory and reactive oxygen species production in 434 vitro (138) . Interestingly, the milk protein-derived inhibitors of the angiotensin-I-converting 435 enzyme may also be involved in the anti-inflammatory process (139) . 
